Miragen Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch MGEN and buy or sell other stocks, ETFs, and their options commission-free!

About MGEN

Miragen Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of proprietary RNA-targeted therapeutics. Its product candidates include cobomarsen, which treats patients with certain cancers, including cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma; and remlarsen and MRG-229, which are made for the treatment of patients with pathological fibrosis. 

CEO
Lee M. Rauch
CEOLee M. Rauch
Employees
46
Employees46
Headquarters
Boulder, Colorado
HeadquartersBoulder, Colorado
Founded
2006
Founded2006
Employees
46
Employees46

MGEN Key Statistics

Market cap
1.30B
Market cap1.30B
Price-Earnings ratio
—
Price-Earnings ratio—
Dividend yield
—
Dividend yield—
Average volume
33.37M
Average volume33.37M
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$2.27
52 Week high$2.27
52 Week low
$0.311
52 Week low$0.311
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.